Trailing-twelve-month (TTM) revenue is $310.70 Million with a year-over-year growth of +43.24%. Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $66,742,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-07 |
| Q4 FY2025Period ended 2025-12-31 | $81,185,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-02-27 |
| Q1 FY2026Period ended 2026-03-31 | $80,181,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-08 |
| Q2 FY2026Period ended 2026-06-30 | $82,591,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-07 |
| TTM revenue | $310,699,000 |
Current P/S: $2,233,220,433 market capitalization ÷ $310,699,000 TTM revenue = 7.19x.
Market capitalization source: FMP quote. Quote observed 2026-10-06T14:45:10.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-30): $82.59M.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T14:47:33.767Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| Aerospace and Defense | $87M | $105M | $88M | $91M | $110M | $175M |
| Industrial | $84M | $95M | $91M |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| Asia Pacific | N/A | N/A | N/A | N/A | N/A | $38M |
| CHINA | $71M | $55M | $21M |
$310.70M
$310.70 Million
+43.24%
vs. $216.91M a year ago (TTM)
+3.80%
5 Year compound annual growth rate
1 Year
+43.24%
3 Year
+11.49%
5 Year
+3.80%
10 Year
N/A
15 Year
N/A
20 Year
N/A
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $261.33M | +$62.78M | +31.62% |
| 2024 | $198.55M | ($11.37M) | (5.42%) |
| 2023 | $209.92M | ($32.14M) | (13.28%) |
| 2022 | $242.06M | ($28.09M) | (10.40%) |
| 2021 | $270.15M | +$47.36M | +21.26% |
| 2020 |
TTM Growth
+43.24%
3-Year CAGR
+11.49%
5-Year CAGR
+3.80%
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 34 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-10-06T14:47:33.767Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
| $46M |
| $39M |
| Microfabrication | $52M | $70M | $63M | $47M | $43M | $47M |
|---|
| $12M |
| $38M |
| N/A |
| EMEA | N/A | N/A | N/A | N/A | N/A | $37M |
|---|
| North America | $108M | $143M | $137M | $129M | $133M | $186M |
|---|
| Rest of World, Excluding China and North America | $44M | $71M | $83M | $69M | $28M | N/A |
|---|
| $222.79M |
| +$46.17M |
| +26.14% |
| 2019 | $176.62M | ($14.74M) | (7.70%) |
| 2018 | $191.36M | +$52.78M | +38.09% |
| 2017 | $138.58M | +$37.26M | +36.77% |
